Skip to main content
. 2023 Mar 7;13:1119744. doi: 10.3389/fonc.2023.1119744

Table 2.

The specific mutational information of six MRD-positive HCC patients.

ID Gene Chromosome Exon c.dot p.dot frequency Variant Type
69168 CREBBP chr16 Exon31+1424 c.6596A>T p.Q2199L 0.003217 Substitution
69168 EZH2 chr7 Exon10-30 c.1209_1211del p.E404del 0.00552 Deletion
69168 TP53 chr17 Exon5+1 c.376T>G p.Y126D 0.003066 Substitution
79060 TP53 chr17 Exon6+48 c.607G>A p.V203M 0.002152 Substitution
52813 NF1 chr17 Exon47-68 c.6995C>G p.S2332* 0.005093 Substitution
63144 EZH2 chr7 Exon2-56 c.62C>G p.S21* 0.003297 Substitution
63144 GLI3 chr7 Exon15+1996 c.4427del p.N1476Tfs*12 0.003307 Deletion
63144 NF1 chr17 Exon3-13 c.276del p.K92Nfs*11 0.003922 Deletion
65536 APC chr5 Exon16-3556 c.7090del p.M2364Cfs*10 0.003487 Deletion
65536 GLI3 chr7 Exon15+1996 c.4427del p.N1476Tfs*12 0.003692 Deletion
92916 TERT chr5 c.-124C>T 0.010394 Substitution
92916 TP53 chr17 Exon7-36 c.747G>T p.R249S 0.010289 Substitution
92916 TP53 chr17 IVS3-2 c.97-2A>T 0.00618 Substitution

HCC, hepatocellular carcinoma; MRD, minimal residual disease.